These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36648136)

  • 21. Latent class analysis to predict intensive care outcomes in Acute Respiratory Distress Syndrome: a proposal of two pulmonary phenotypes.
    Wendel Garcia PD; Caccioppola A; Coppola S; Pozzi T; Ciabattoni A; Cenci S; Chiumello D
    Crit Care; 2021 Apr; 25(1):154. PubMed ID: 33888134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum metabolomic signatures of fatty acid oxidation defects differentiate host-response subphenotypes of acute respiratory distress syndrome.
    Suber TL; Wendell SG; Mullett SJ; Zuchelkowski B; Bain W; Kitsios GD; McVerry BJ; Ray P; Ray A; Mallampalli RK; Zhang Y; Shah F; Nouraie SM; Lee JS
    Respir Res; 2023 May; 24(1):136. PubMed ID: 37210531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study.
    Sinha P; Delucchi KL; Thompson BT; McAuley DF; Matthay MA; Calfee CS;
    Intensive Care Med; 2018 Nov; 44(11):1859-1869. PubMed ID: 30291376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials.
    Calfee CS; Delucchi K; Parsons PE; Thompson BT; Ware LB; Matthay MA;
    Lancet Respir Med; 2014 Aug; 2(8):611-20. PubMed ID: 24853585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Machine learning-based COVID-19 acute respiratory distress syndrome phenotyping and clinical outcomes: A systematic review.
    Tenda ED; Henrina J; Samosir J; Amalia R; Yulianti M; Pitoyo CW; Setiati S
    Heliyon; 2023 Jun; 9(6):e17276. PubMed ID: 37366530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fluid Therapy and Acute Respiratory Distress Syndrome.
    Lee J; Corl K; Levy MM
    Crit Care Clin; 2021 Oct; 37(4):867-875. PubMed ID: 34548138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypes in acute respiratory distress syndrome: moving towards precision medicine.
    Sinha P; Calfee CS
    Curr Opin Crit Care; 2019 Feb; 25(1):12-20. PubMed ID: 30531367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of distinct clinical phenotypes of acute respiratory distress syndrome with differential responses to treatment.
    Liu X; Jiang Y; Jia X; Ma X; Han C; Guo N; Peng Y; Liu H; Ju Y; Luo X; Li X; Bu Y; Zhang J; Liu Y; Gao Y; Zhao M; Wang H; Luo L; Yu K; Wang C
    Crit Care; 2021 Aug; 25(1):320. PubMed ID: 34461969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolomics profile in acute respiratory distress syndrome by nuclear magnetic resonance spectroscopy in patients with community-acquired pneumonia.
    Yan Y; Chen J; Liang Q; Zheng H; Ye Y; Nan W; Zhang X; Gao H; Li Y
    Respir Res; 2022 Jun; 23(1):172. PubMed ID: 35761396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort.
    Ceccato A; Forne C; Bos LD; Camprubí-Rimblas M; Areny-Balagueró A; Campaña-Duel E; Quero S; Diaz E; Roca O; De Gonzalo-Calvo D; Fernández-Barat L; Motos A; Ferrer R; Riera J; Lorente JA; Peñuelas O; Menendez R; Amaya-Villar R; Añón JM; Balan-Mariño A; Barberà C; Barberán J; Blandino-Ortiz A; Boado MV; Bustamante-Munguira E; Caballero J; Carbajales C; Carbonell N; Catalán-González M; Franco N; Galbán C; Gumucio-Sanguino VD; de la Torre MDC; Estella Á; Gallego E; García-Garmendia JL; Garnacho-Montero J; Gómez JM; Huerta A; Jorge-García RN; Loza-Vázquez A; Marin-Corral J; Martínez de la Gándara A; Martin-Delgado MC; Martínez-Varela I; Messa JL; Muñiz-Albaiceta G; Nieto MT; Novo MA; Peñasco Y; Pozo-Laderas JC; Pérez-García F; Ricart P; Roche-Campo F; Rodríguez A; Sagredo V; Sánchez-Miralles A; Sancho-Chinesta S; Socias L; Solé-Violan J; Suarez-Sipmann F; Tamayo-Lomas L; Trenado J; Úbeda A; Valdivia LJ; Vidal P; Bermejo J; Gonzalez J; Barbe F; Calfee CS; Artigas A; Torres A;
    Crit Care; 2024 Mar; 28(1):91. PubMed ID: 38515193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying novel clinical phenotypes of acute respiratory distress syndrome using trajectories of daily fluid balance: a secondary analysis of randomized controlled trials.
    Wu F; Shi S; Wang Z; Wang Y; Xia L; Feng Q; Hang X; Zhu M; Zhuang J
    Eur J Med Res; 2024 May; 29(1):299. PubMed ID: 38807163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A targeted metabolomics approach for sepsis-induced ARDS and its subphenotypes.
    Chang Y; Yoo HJ; Kim SJ; Lee K; Lim CM; Hong SB; Koh Y; Huh JW
    Crit Care; 2023 Jul; 27(1):263. PubMed ID: 37408042
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The precision medicine for the treatment of acute respiratory distress syndrome is based on identification of phenotypes].
    Liu YN; Ma XC
    Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(15):1253-1257. PubMed ID: 38637165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Latent class analysis of imaging and clinical respiratory parameters from patients with COVID-19-related ARDS identifies recruitment subphenotypes.
    Filippini DFL; Di Gennaro E; van Amstel RBE; Beenen LFM; Grasso S; Pisani L; Bos LDJ; Smit MR
    Crit Care; 2022 Nov; 26(1):363. PubMed ID: 36434629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.
    Calfee CS; Delucchi KL; Sinha P; Matthay MA; Hackett J; Shankar-Hari M; McDowell C; Laffey JG; O'Kane CM; McAuley DF;
    Lancet Respir Med; 2018 Sep; 6(9):691-698. PubMed ID: 30078618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kynurenine Pathway of Tryptophan Metabolism Is Associated with Hospital Mortality in Patients with Acute Respiratory Distress Syndrome: A Prospective Cohort Study.
    Chiu LC; Tang HY; Fan CM; Lo CJ; Hu HC; Kao KC; Cheng ML
    Antioxidants (Basel); 2022 Sep; 11(10):. PubMed ID: 36290606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological Phenotyping in Sepsis and Acute Respiratory Distress Syndrome.
    Sinha P; Meyer NJ; Calfee CS
    Annu Rev Med; 2023 Jan; 74():457-471. PubMed ID: 36469902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations of the plasma lipidome with mortality in the acute respiratory distress syndrome: a longitudinal cohort study.
    Maile MD; Standiford TJ; Engoren MC; Stringer KA; Jewell ES; Rajendiran TM; Soni T; Burant CF
    Respir Res; 2018 Apr; 19(1):60. PubMed ID: 29636049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating microparticle levels are reduced in patients with ARDS.
    Shaver CM; Woods J; Clune JK; Grove BS; Wickersham NE; McNeil JB; Shemancik G; Ware LB; Bastarache JA
    Crit Care; 2017 May; 21(1):120. PubMed ID: 28545548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneous phenotypes of acute respiratory distress syndrome after major trauma.
    Reilly JP; Bellamy S; Shashaty MG; Gallop R; Meyer NJ; Lanken PN; Kaplan S; Holena DN; May AK; Ware LB; Christie JD
    Ann Am Thorac Soc; 2014 Jun; 11(5):728-36. PubMed ID: 24712298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.